Team:KULeuven/Zandbak/Home2
From 2008.igem.org
(New page: {{:Team:KULeuven/Tools/Header}} <!-- Explaining the structure: The homepage is divides into a main and a sidebar area, the sidebar is seen to the right, while the main area keeps to the ...) |
m |
||
Line 18: | Line 18: | ||
<!-- CSS --> | <!-- CSS --> | ||
<style type="text/css" media="screen, projection"> | <style type="text/css" media="screen, projection"> | ||
- | @import url(http://www.student.kuleuven.be/~s0173901/wiki/css/home.css); | + | @import url(http://www.student.kuleuven.be/~s0173901/wiki/css/home-exp.css); |
@import url(http://www.student.kuleuven.be/~s0173901/wiki/css/ui.tabs.css); | @import url(http://www.student.kuleuven.be/~s0173901/wiki/css/ui.tabs.css); | ||
@import url(http://www.google.com/cse/api/branding.css); | @import url(http://www.google.com/cse/api/branding.css); | ||
Line 57: | Line 57: | ||
__NOTOC__ | __NOTOC__ | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<div id="homeArea"> | <div id="homeArea"> | ||
+ | <html> | ||
<!-- 1. HEADER --> | <!-- 1. HEADER --> | ||
<div id="homeHeader"> | <div id="homeHeader"> | ||
Line 102: | Line 73: | ||
- | + | ||
<!-- 2. CONTENT --> | <!-- 2. CONTENT --> | ||
<div id="homeContent"> | <div id="homeContent"> |
Revision as of 09:14, 20 August 2008
Wellcome to the KULeuven 2008 iGEM team page!
The ''2008 iGEM team of the Katholieke Universiteit Leuven'' works on '''a bacterial drug delivery system''', for instance for the production of a peptide such as vasoactive intestinal peptide as a potential treatment for Crohn's disease. The bacterial drug delivery system will have ''several advantages over classical drugs''. These are (a) the bacterium will produce the exact amount of drug necessary for each individual by means of a feedback control mechanism, (b) the bacterium will die upon a long symptomless period and (c) a possible development towards drugs being taken up in the bloodstream.
...
BioScenter
Synthetic biology is a new challenge in biosciences. It combines biology and engineering principles to design and build new biological functions and systems. Examples are abound: cancer cell invading bacteria, microbes that take pictures, antimalarial drug producers,... The advantage of using living systems for these purposes is that, once they are designed and built, they are self-reproducible. The challenge, however lies exactly within the design and construction: making biological circuits and devices as robust and predictive as their electrical counterparts. ...
The international Genetically Engineered Machine competition (iGEM) or iGEM competition is a synthetic biology competition for multidisciplinary teams of undergraduate students. It was first organized in 2004 by Drew Endy, Randy Rettberg and Tom Knight of MIT with two goals in mind: to yield new ideas in synthetic biology and to form the future researchers in this new scientific community. Whereas 5 US teams competed in 2004, the 2007 edition already had 750 students and advisors grouped in 54 teams from 19 countries. This year, the competition already counts 83 teams!
The core of the iGEM competition is to design and build a “new genetic machine” with BioBricks. BioBricks are standardized, off the shelf biological parts that are used by genetic network designers. All BioBricks that were made during previous iGEM competitions are registered and documented in the Registry of Standard Biological Parts. Each iGEM competition thus starts from the efforts of the previous years.
Leuven
This is the first kuleuven ... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing... Testing...
The Team
- Maarten Breckpot
-
Maarten Breckpot
Studies:
1st Master of Applied Sciences and Engineering – Mathematical Engineering
Country:
Belgium - Nick Van Damme
-
Nick Van Damme
Studies:
1st Master of Applied Sciences and Engineering – Mathematical Engineering
Country:
Belgium - Benjamien Moeyaert
-
Benjamien Moeyaert
Studies:
3rd Bachelor of Biochemistry and Biotechnology
Country:
Belgium - Stefanie Roberfroid
-
Stefanie Roberfroid
Studies:
3rd Bachelor of Bioscience Engineering – Biomolecular Engineering
Country:
Belgium - Dries Vercruysse
-
Dries Vercruysse
Studies:
1st Master of Applied Sciences and Engineering - Nanoscience and Nanotechnology
Country:
Belgium - Andim Doldurucu
-
Andim Doldurucu
Studies:
1st Master of Bioscience Engineering – Nanoscience and Nanotechnology
Country:
Turkey - Hanne Tytgat
-
Hanne Tytgat
Studies:
3rd Bachelor of Biochemistry and Biotechnology
Country:
Belgium - Elke Van Assche
-
Elke Van Assche
Studies:
3rd Bachelor of Bioscience Engineering – Biomolecular Engineering
Country:
Belgium - Jan Mertens
-
Jan Mertens
Studies:
1st Master of Bioscience Engineering – Biomolecular Engineering
Country:
Belgium - Nathalie Busschaert
-
Nathalie Busschaert
Studies:
3rd Bachelor of Chemistry
Country:
Belgium - Jonas Demeulemeester
-
Jonas Demeulemeester
Studies:
1st Master of Biochemistry and Biotechnology
Country:
Belgium - Antoine Vandermeersch
-
Antoine Vandermeersch
Studies:
2nd and 3rd Bachelor of Applied Sciences and Engineering – Electrical and Materials Engineering
Country:
Belgium
The Project